SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of business segments

	Cure			Sera Labs			Eliminations			Consolidated
Net Sales	$	279		$	3,327		$	(51	)	$	3,555
Operating Loss	$	(4,116	)	$	(3,647	)	$	-		$	(7,763	)
Assets	$	43,956		$	14,651		$	(14,175	)	$	44,432
Accounts receivable, net	$	36		$	206		$	-		$	242
Inventory, net	$	336		$	495		$	-		$	831

	Cure			Sera Labs		Eliminations		Consolidated
Net Sales	$	549		$	-	$	-	$	549
Operating Loss	$	(11,485	)	$	-	$	-	$	(11,485	)
Assets	$	30,157		$	-	$	-	$	30,157
Accounts receivable, net	$	43		$	-	$	-	$	43
Inventory, net	$	210		$	-	$	-	$	210

Schedule of disaggregation of revenue

	Three Months Ended						Six Months Ended
	June 30, 2021			June 30, 2020			June 30, 2021			June 30, 2020
CureFilm™ sales		4	%		61	%		7	%		67	%
Research & Development services		1			37			1			31
Product sales - CBD		78			-			82			-
Product sales - PPE		17			-			10			-
Total		100	%		98	%		100	%		98	%